Wall Street brokerages expect Danaher Co. (NYSE:DHR) to post $5.09 billion in sales for the current fiscal quarter, according to Zacks Investment Research. Six analysts have made estimates for Danaher’s earnings, with the highest sales estimate coming in at $5.12 billion and the lowest estimate coming in at $5.07 billion. Danaher reported sales of $4.98 billion in the same quarter last year, which indicates a positive year-over-year growth rate of 2.2%. The firm is expected to issue its next quarterly earnings report on Thursday, July 18th.

On average, analysts expect that Danaher will report full-year sales of $20.56 billion for the current fiscal year, with estimates ranging from $20.46 billion to $20.61 billion. For the next fiscal year, analysts anticipate that the firm will post sales of $22.53 billion, with estimates ranging from $21.41 billion to $24.75 billion. Zacks’ sales averages are a mean average based on a survey of research firms that follow Danaher.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Thursday, April 18th. The conglomerate reported $1.07 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.01 by $0.06. The business had revenue of $4.88 billion during the quarter, compared to the consensus estimate of $4.80 billion. Danaher had a net margin of 12.04% and a return on equity of 11.61%. The firm’s quarterly revenue was up 3.9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.99 earnings per share.

Several brokerages have issued reports on DHR. Zacks Investment Research downgraded shares of Danaher from a “hold” rating to a “sell” rating in a research note on Tuesday, April 30th. Janney Montgomery Scott raised their price objective on shares of Danaher from $136.00 to $174.00 and gave the stock a “buy” rating in a research note on Wednesday, April 17th. JPMorgan Chase & Co. reissued an “overweight” rating and issued a $140.00 price objective on shares of Danaher in a research note on Monday, March 4th. Needham & Company LLC reissued a “buy” rating and issued a $138.00 price objective (up previously from $114.00) on shares of Danaher in a research note on Thursday, February 28th. Finally, UBS Group lifted their price target on shares of Danaher from $125.00 to $144.00 and gave the company a “buy” rating in a research note on Tuesday, February 26th. Two equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $131.75.

In related news, Chairman Mitchell P. Rales purchased 1,900 shares of the firm’s stock in a transaction dated Friday, May 10th. The stock was purchased at an average price of $130.78 per share, with a total value of $248,482.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP William K. Daniel sold 7,534 shares of Danaher stock in a transaction that occurred on Tuesday, May 21st. The shares were sold at an average price of $131.27, for a total transaction of $988,988.18. Following the sale, the executive vice president now directly owns 115,778 shares of the company’s stock, valued at approximately $15,198,178.06. The disclosure for this sale can be found here. Insiders have sold 462,566 shares of company stock valued at $59,987,905 in the last ninety days. Insiders own 11.40% of the company’s stock.

A number of hedge funds have recently modified their holdings of the stock. Adirondack Trust Co. increased its holdings in Danaher by 3.1% during the first quarter. Adirondack Trust Co. now owns 2,635 shares of the conglomerate’s stock valued at $349,000 after buying an additional 78 shares during the period. HL Financial Services LLC increased its holdings in Danaher by 0.4% during the first quarter. HL Financial Services LLC now owns 19,148 shares of the conglomerate’s stock valued at $2,528,000 after buying an additional 79 shares during the period. Cornerstone Advisors Inc. increased its holdings in Danaher by 2.9% during the first quarter. Cornerstone Advisors Inc. now owns 2,783 shares of the conglomerate’s stock valued at $367,000 after buying an additional 79 shares during the period. WealthBridge Capital Management LLC grew its holdings in Danaher by 5.1% in the first quarter. WealthBridge Capital Management LLC now owns 1,633 shares of the conglomerate’s stock worth $214,000 after purchasing an additional 79 shares during the last quarter. Finally, First Personal Financial Services grew its holdings in Danaher by 13.7% in the first quarter. First Personal Financial Services now owns 664 shares of the conglomerate’s stock worth $88,000 after purchasing an additional 80 shares during the last quarter. 79.98% of the stock is currently owned by institutional investors.

NYSE DHR traded up $0.41 during trading on Friday, hitting $132.04. The stock had a trading volume of 1,789,555 shares, compared to its average volume of 2,227,649. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.18 and a quick ratio of 1.74. The company has a market cap of $94.53 billion, a P/E ratio of 29.21, a PEG ratio of 2.52 and a beta of 1.02. Danaher has a one year low of $94.59 and a one year high of $134.67.

The business also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 0.51%. The ex-dividend date of this dividend is Thursday, June 27th. Danaher’s dividend payout ratio is presently 15.04%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Read More: Why is total return important?

Get a free copy of the Zacks research report on Danaher (DHR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.